NCT04296045已完成不适用
A Randomised, Double-blind, Placebo-controlled, Cross-over Study, to Investigate the Effect of Maize Cob Extract on Post-prandial Glucose and Insulin Responses in Healthy Males
Cambridge Glycoscience1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2020年7月2日最近更新:
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 10
- 试验地点
- 1
- 主要终点
- Difference in venous glucose from incremental area under the curve (iAUC) (T-15 to T120 minutes)
研究概览
简要总结
Maize Cob Extract (MCE) is intended to be used as a bulking agent in food. The purpose of this study is to determine the glycaemic and insulinemic response of MCE consumed in isolation compared to glucose; the glycaemic and insulinemic response will also be determined for MCE alone and in combination with glucose. This is a randomised, double-blind, single-centre trial in 10 healthy male participants.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Other
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Be able to give written informed consent;
- •Be between 18 and 60 years of age inclusive;
- •Have a body mass index <30 Kg/m2;
- •Have a fasting glucose level of ≤6.0 mmol/L
- •Be in general good health, as determined by the investigator;
- •Be willing to fast for at least 10 hours before the study visit.
排除标准
- •The presence of any of the following criteria will exclude the participant from participating in the study:
- •Are less than 18 or greater than 60 years of age;
- •Recent gastroenteritis or food borne illness such as confirmed food poisoning within the past 4 weeks;
- •Have taken a medication or dietary supplement that may influence GI activity within the 2-weeks prior to screening;
- •Have a history of abdominal surgery (excluding appendectomy);
- •Have taken anaesthesia within the past 4 weeks;
- •Have taken antibiotics within the past 12-weeks;
- •Have a recent history of drug and/or alcohol abuse at the time of enrolment;
- •Are a smoker (defined as >5 cigarettes/week);
- •Have made any major dietary change in the past 3 months;
- •Have planned major changes in lifestyle (i.e. diet, dieting, exercise level, travelling) during the duration of the study;
- •Have an active gastrointestinal disorder or previous gastrointestinal surgery;
- •Have irritable bowel syndrome, diagnosed or undiagnosed and treated with chronic medications;
- •Have a metabolic or endocrine disorder such as diabetes, thyroidism, or other metabolic disorder;
- •Have a severe chronic disease i.e. cancer, renal failure, hepatitis, HIV, cirrhosis etc., or with a history of such diseases;
- •Have a gastrointestinal disease i.e., chronic diarrhoea, Crohn's disease, ulcerative colitis, diverticulosis, stomach or duodenal ulcers, or with a history of such diseases;
- •Are severely immunocompromised (HIV positive, transplant patient, on antirejection medications, on a systemic steroid for >30 days, or chemotherapy or radiotherapy within the last year);
- •Experiences alarm features such as weight loss, rectal bleeding, recent change in bowel habit (<3 months) or abdominal pain;
- •Participants who, in the opinion of the investigator, are considered to be poor attendees or unlikely for any reason to be able to comply with the trial;
- •Participant is currently receiving treatment involving experimental drugs. If the participant has been in a recent experimental trial, these must have been completed not less than 30 days prior to this study
研究组 & 干预措施
MCE
Experimental
干预措施: MCE (Dietary Supplement)
MCE + Glucose
Experimental
干预措施: MCE (Dietary Supplement)
Glucose
Active Comparator
Glucose
干预措施: Glucose (Dietary Supplement)
MCE + Glucose
Experimental
干预措施: Glucose (Dietary Supplement)
结局指标
主要结局
Difference in venous glucose from incremental area under the curve (iAUC) (T-15 to T120 minutes)
时间窗: Through intervention periods of two hours
次要结局
- Difference in venous insulin from incremental area under the curve (iAUC) (T-15 to T120 minutes)(Through intervention periods of two hours)
- Maximal concentrations for glucose and insulin (Cmax)(Through intervention periods of two hours)
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Study of Changes in Total Cholesterol Levels as a Function of Consuming a Supplement Designed to Improve Cardiovascular HealthHypercholesteremiaHyperlipidemiaCholesterolNCT01890889Integrative Health Technologies, Inc.150
Unknown
4 期
Yunzhi as Dietary Supplement in Breast CancerBreast CancerNCT00647075Hospital Clinic of Barcelona60
招募中
不适用
Effectiveness of a Novel Dietary Ingredient on Hair Growth and Skin's AppearanceSkin AgeingHair ThinningFacial Skin TextureNCT06010745Nutrition 21, Inc.101
撤回
2 期
A Placebo-Controlled, Randomized, Safety and Efficacy Study to Evaluate the Change in Hemoglobin A1c Levels in Type 2 Diabetic Subjects While Taking NutralinDiabetesNCT01275027Avera McKennan Hospital & University Health Center
招募中
不适用
Dietary Supplementation on Body Fat CompositionPre-diabetesDyslipidemiasNCT06296251Brightseed150